Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2020

View Archived Issues

Celiac model captures gluten, genetics and gut reactions

Autophagy helps repair lung injury

Strengthening lysosomes could head Parkinson's off at the pass

Neuropore receives a grant to developTLR2 agonist for ALS

PYC receives NHMRC grant to identify new antisense drugs

Arcus initiates phase II study of zimberelimab monotherapy and with immunotherapies in NSCLC

ModraDoc006 shows promising efficacy and safety in phase I study in mCRPC

Pfizer presents first interim analysis data from TALAPRO-1 study of talazoparib

Phase I data for guadecitabine plus cisplatin in patients with platinum-refractory GCT

Roche, Genentech describe new MEKKK1 inhibitors

New tachykinin NK1 receptor antagonists identified at XW Laboratories

Inventiva discloses new PPAR agonists

Mutabilis patents bacterial beta-lactamase inhibitors

Preclinical data presented for SIG-007 in models of Fabry disease

PD-1/PD-L1 interaction inhibitors described by Shanghai Ennova Biopharmaceutical

Progranulin gene therapy has therapeutic effects in knockout model

KRT5 and KRT20 found to predict treatment response in patients with muscle-invasive bladder cancer

PSA declines seen with 225Ac-DOTA-J591 in mCRPC trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...